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Abstract In the present study we focused on the in vitro
and in vivo evaluation of two types of carbon ﬁbres (CFs):
hydroxyapatite modiﬁed carbon ﬁbres and porous carbon
ﬁbres. Porous CFs used as scaffold for tissues regeneration
could simultaneously serve as a support for drug delivery
or biologically active agents which would stimulate the
tissue growth; while addition of nanohydroxyapatite to CFs
precursor can modify their biological properties (such as
bioactivity) without subsequent surface modiﬁcations,
making the process cost and time effective. Presented
results indicated that ﬁbre modiﬁcation with HAp pro-
moted formation of apatite on the ﬁbre surface during
incubation in simulated body ﬂuid. The materials bio-
compatibility was determined by culturing human osteo-
blast-like cells of the line MG 63 in contact with both types
of CFs. Both tested materials gave good support to adhe-
sion and growth of bone-derived cells. Materials were
implanted into the skeletal rat muscle and a comparative
analysis of tissue reaction to the presence of the two types
of CFs was done. Activities of marker metabolic enzymes:
cytochrome c oxidase (CCO) and acid phosphatase were
examined to estimate the effect of implants on the meta-
bolic state of surrounding tissues. Presented results evi-
dence the biocompatibility of porous CFs and activity that
stimulates the growth of connective tissues. In case of CFs
modiﬁed with hydroxyapatite the time of inﬂammatory
reaction was shorter than in case of traditional CFs.
1 Introduction
Carbon ﬁbres (CFs) have been widely investigated as
potential constituents of medical devices for structural
ﬁxation of bone fragments, bone substitutes, cellular
growth supports in tissue engineering etc. [1]. Biocom-
patibility of CFs has been the subject of numerous
researches. Some of investigators concluded that CFs
induce the growth of new tissue [2], however, there were
also announcements questioning biocompatibility of CFs
[3–5]. The different opinions regarding biocompatibility of
CFs may be explained by the use of different types of CFs
of different physical, structural and chemical properties,
resulting from many technological parameters [3, 6]. It has
been demonstrated [1, 6, 7] that the cellular response to the
ﬁbrous carbon material depends on the degree of crystal-
linity of the material; therefore only selected types of CFs
are suitable for tissue treatment purposes.
Carbon ﬁbres have been used in the reconstruction of
parallel-ﬁbred tissue such as ligaments and tendons. They
induce proliferation of ordered collagenous ﬁbrous tissue in
the direction of the carbon ﬁbre ﬁlaments [2, 8]. Various
ﬁbrous forms of carbon materials have been also tested for
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[10] to ﬁll the tissue losses of rabbit’s cartilages [11] as well
as in bone defect treatment [9]. Beside CFs were widely
applicable in composite materials for medicine. The use of
CFs as the modifying phase increase the strength of the
polymer/carbon composite and the ﬁbres uncovered after
polymerresorptionprocesscanserveasthescaffoldforbone
tissue regeneration [12]. Composite carbon biomaterials
have been also used in orthopedics to manufacture plates
[13], screws [14] and elements of external stabilizers for
osteosynthesis, hip joint endoprostheses [15] and also some
types of medical equipment [16, 17]. Controlled modiﬁca-
tion of the surface of carbon biomaterials can change the
effect or function of immunological cells response [7].
Research on CFs coated with a layer of pyrolytic carbon
indicated that such implants have stimulated tissue regen-
eration [9].
Carbon ﬁbres are biocompatible even though they are
not bioactive in an extent comparable to properties of
bioglasses or bioceramics [18], so that modiﬁcation of CFs’
surface with ceramic particles such as hydroxyapatite
(HAp) is increasingly practiced [19, 20].
It is well know that HAp binds with the bone by the
bone-like apatite layer which is formed in biological
environment on the HAp surface [21]. It is believed
that formation of apatite leads to chemical bonding on the
implant–bone interface [22].
The primary objective of this study was the biological
evaluation of two types of new CFs which are perspective
to be used for creation of three-dimensional scaffolds for
tissue engineering. Among the possible forms of implants,
ﬁbrous matrices are highly promising for the tissue
regeneration by acting as a cell-supporting scaffold. It may
be expected that application of carbon fabrics composed of
porous ﬁbres or ﬁbres modiﬁed with HAp nanoparticles
would have regenerative potential in the treatment of bone
diseases. Porous carbon ﬁbre used as scaffold for tissues
regeneration could simultaneously serve as a support for
drug delivery or biologically active agents which would
stimulate the tissue growth; while addition of nanohydr-
oxyapatite to CFs precursor can modify their biological
properties without subsequent surface modiﬁcations, mak-
ing the process cost and time effective. Therefore, in this
study, we investigated the behaviour of porous and nano-
HAp-modiﬁed CFs in biological environments and their
interaction with cells and tissues under in vitro and in vivo
conditions.
2 Materials and methods
Fortheseinvestigationporouspolyacrylonitrile(PAN)ﬁbres
andﬁbrescontainingnanohydroxyapatite(HAp)preparedat
the Technical University of Lo ´dz ´ were selected. Fibres were
obtained using PAN-terpolymer from Zoltek (Hungary) of
the following composition: 93–94% of weight meres of
acrylonitrile, 5–6% of weight meres of methyl acrylate and
about 1% of weight meres of alilosulphoniane. Dimethyl-
formamide (DMF) was used as a solvent. Hydroxyapatite
(HAp) used in the study was provided by the University of
Science and Technology (Cracow, Poland) [23]. The spe-
ciﬁc surface area of the HAp powder was 71.4 m
2/g. HAp
(3% w/w) were added to PAN spinning solution. Porous
ﬁbres as well as ﬁbres with and without HAp powder were
spun as described elsewhere [24, 25].
Carbon ﬁbres used in this study were prepared by
thermal treatment of three types of PAN precursor ﬁbres
via two-stage process, starting from thermal treatment in
air atmosphere at 150–280 C followed by carbonization in
an atmosphere of pure argon at 1,000 C. Details of the
thermal transformation of the PAN precursor ﬁbres into
CFs are given in previous works [26]. The average diam-
eter of the ﬁbres after carbonization process was 10 lm.
Three following different types of ﬁbres were selected:
(1) Porous carbon ﬁbres (CF/P)
(2) Carbon ﬁbres modiﬁed with hydroxyapatite (CF/HAp)
(3) Carbon ﬁbres—standard, not modiﬁed (CF/T)
Microstructure and chemical composition of CFs were
characterized using scanning electron microscopes: NOVA
NANO SEM 200, FEJ EUROPE COMPANY, Jeol, JSM-
5500 and Jeol, JSM-5400 equipped with EDS Link ISIS
300 device for chemical analysis of micro-areas.
2.1 In vitro bioactivity testing in SBF
Carbon ﬁbres modiﬁed with HAp (CF/HAp) and reference
standard non-modiﬁed carbon ﬁbres (CF/T) were incubated
for 20 days in 50 ml of simulated body ﬂuid (SBF) (pH
7.4; 37 C), in closed polyethylene containers. SBF solu-
tion, also referred as artiﬁcial blood plasma, was prepared
according to the procedure described by Kokubo [27]. The
SBF solutions were collected for determination of calcium
(Ca) and phosphorous (P) ion concentration changes by
inductively coupled plasma atomic emission spectroscopy
(ICP-AES, PLASMA 40, Perkin Elmer). After 20 days the
samples were separated, rinsed with water and dried at
room temperature. Surface morphology before and after
incubation in artiﬁcial plasma (SBF) was evaluated using
scanning electron microscopy (SEM, Jeol JSM-5400).
2.2 Cell culture
InvitrotestsincellcultureswereperformedintheInstituteof
Physiology, Academy of Sciences of the Czech Republic,
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CF/T ﬁbres were subjected to thermal sterilization at the
temperature of 160 C for 120 min.
For testing the cell–material interaction in vitro, human
osteoblast-like MG-63 cells (European Collection of Cell
Cultures, Salisbury, UK) were used. Although these cells
were derived from osteosarcoma, they retained important
markers of osteogenic cell differentiation, such as the
activity of alkaline phosphatase and production osteocal-
cin, thus they can serve as a good in vitro model for testing
the compatibility of various materials with bone cells [28].
Fibrous samples were inserted into polystyrene multidishes
(24 wells, diameter 15 mm, TPP Company, Trasadingen,
Switzerland), and seeded with MG-63 cells. Each well
contained 10 ﬁbres (each 1 cm long), 50,000 cells/well and
1.5 ml of Dulbecco’s Modiﬁed Eagle Medium supple-
mented with 10% of fetal bovine serum and gentamicin
(40 lg/ml). Conventional cell culture support, i.e. the
bottom of polystyrene dishes served as a control material.
Cells were incubated at 37 C in air atmosphere with 5%
CO2. After 1, 3 and 7 days of incubation, the samples were
rinsed in phosphate-buffered saline (PBS), ﬁxed in 70%
cold ethanol (-20 C, 5 min), visualized by staining with
propidium iodide (concentration 5 lg/ml in PBS, incuba-
tion 5 min at room temperature), and their morphology and
distribution was evaluated and documented using epiﬂuo-
rescence microscope IX 51 equipped with a digital camera
DP 70 (Olympus, Japan).
Effects of the tested materials on the adhesion, growth
and morphology of cells on the ﬁbres as well as on the
underlying well bottom were evaluated. For separate
counting of cell number on the ﬁbres and on the well bot-
toms, the ﬁbres were carefully moved to fresh wells without
their damage or cell detachment. Both groups of cells were
then rinsed in PBS and exposed to 0.1% trypsin solution in
PBS (pH 7.35, temperature 37 C, 5 min) in order to release
the cells from the materials. Cells were counted in a
Burker’s hemocytometer using an inverted optical micro-
scope (Olympus IX 51). Statistical signiﬁcance of the dif-
ferences between the experimental groups was estimated
using ANOVA, Student–Newman–Keuls method.
2.3 In vivo study
The rat skeletal muscle was used as model tissue for in vivo
studies, due to the composition of the muscle, which apart
from striated muscle cells contains also nerve ﬁbres, con-
nective tissue and blood vessels. The cell response of soft
tissues to the synthetic implanted material is more intensive
and processes of soft tissue regeneration are more difﬁcult.
Moreover, in clinical practice, the probability of contact of
the material used for ﬁlling bone loses with surrounding
tissues including muscles is high.
The experiment was performed according to the EU ISO
10993-6 guidelines and the study protocol was approved
by the I Local Bioethics Committee in Cracow, Poland
(No. 32/2003).
Carbon ﬁbres (CF/HAp, CF/P) used in the experiment
were sterilized in a dry hot air sterilizer in 160 C/120 min.
Next they were implanted under sterile conditions into the
gluteus muscle of 20 adult male Hooded Oxford (HO/Krf)
inbred rats. Animals were anesthetized with pentobarbita-
lum (Vetbutal, Biowet Puławy, Poland). Skin in the site of
surgery was shaved and disinfected, and a small incision
was made to create a 4 mm deep pouch in the gluteus
muscle. Equal portions (10 mg) of the CFs were inserted
into the pouch. The muscle and skin wounds were closed
with 5/0 PDS II (polydioxanone) monoﬁlament absorbable
sutures (Ethicon Ltd., UK). All animals survived the sur-
gery. No wound healing complications were observed after
the surgery and during the whole experiment. The animals
were maintained under standard conditions with free access
to food and water.
After 7, 30, 90, 150 and 210 days from the surgery, at
each time point 4 animals were sacriﬁced with an overdose
of Vetbutal. Tissue specimens containing the implanted
material were excised and immediately frozen in liquid
nitrogen. Next they were cut into 8 lm thick slides in a
Pearse–Slee cryostat at -22 C. In order to estimate the
processes of tissue regeneration and the tissue-implant
interface, the obtained slides were examined by histologi-
cal and histochemical reactions.
The metabolic state of tissues surrounding the implants
was estimated by measuring activities of the following
enzymes: cytochrome c oxidase (CCO), and glucose-6-
phosphate dehydrogenase. The relative number of inﬂam-
matory cells revealed by May–Gru ¨nwald–Giemsa method
and the activity of a hydrolytic enzyme—acid phospha-
tase—were used to assess the extent of inﬂammation around
the implant. The presence and thickness of ﬁbrous capsule
was assessed on slides stained by Van Gieson’s method.
Observations were made using an optical microscope
BX (Olympus, Germany), and pictures were taken with a
digital camera CAMEDIA (Olympus, Germany).
3 Results
Microstructure of materials used in this study can be
observed in Figs. 1 and 2. Particles (nanoparticle agglom-
erates) of calcium phosphate are clearly visible on the CF/
HAp ﬁbres surface (Fig. 1). Elongated pores of various
sizes were found on the surface of CF/P ﬁbres (Fig. 2). The
analysis of the ﬁbres cross-section shows that the pores
occurred at the outer layer of the ﬁbres and formed irreg-
ular channels along the ﬁbre axis.
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The surface of HAp modiﬁed carbon ﬁbres (CF/HAp)
before incubation in SBF was relatively smooth with
small and sporadic prominences on the material surface
(Fig. 3a). During the incubation in SBF, the character of
the ﬁbre surface has been markedly changed by abundant
deposits (Fig. 3b, c), which were then analyzed by EDS
method (Fig. 4). EDS analysis indicated the presence of
oxygen, phosphorous and calcium ions on the surface
suggested the presence of a newly formed apatite on the
CF/HAp surface.
Changes of ion concentration in SBF solution during
CF/HAp incubation are presented in Fig. 4c. In contrast to
slowly increasing concentration of Ca ions, the concen-
tration of P ions in SBF gradually decreases. Formation of
Ca–P layer on the ﬁbres surface is dependent on absorption
of Ca ions from the solution, simultaneously the
hydroxyapatite embedded in ﬁbres is gradually solubilized
and calcium ions are liberated. Based on Fig. 4c it can be
supposed that more ions were released from ﬁbres than
absorbed from solution, so that the slight increase of cal-
cium ion concentration is observed. On the other hand
decreased concentration of phosphorus ions in SBF solu-
tion can be assigned to P ions consumption needed to
formation of apatite layer. Obtained results support the
statement that when calcium phosphate in organic matrix is
heated up to 1,000 C, it decomposes, and as a result of
Fig. 1 Scanning electron microscope (Jeol, JSM-5400, NOVA NANO SEM 200, FEJ EUROPE COMPANY) images of CFs with HAp particles
(CF/HAp): a magniﬁcation 10009, bar = 20 lm; b magniﬁcation 60009, bar = 20 lm and c magniﬁcation 200009, bar = 5 lm
Fig. 2 Scanning electron microscope (Jeol, JSM-5400) images of porous carbon ﬁbres CF/P: a magniﬁcation 70009, bar = 5 lm;
b magniﬁcation 25009, bar = 20 lm and c magniﬁcation 70009, bar = 5 lm
Fig. 3 CF/HAp surfaces before (a) and after (b, c) immersion in SBF. Scanning electron microscope (Jeol, JSM-5400; Jeol, JSM-5500):
a magniﬁcation 10009, bar = 20 lm; b magniﬁcation 10009, bar 50 = lm, and c magniﬁcation 10009, bar = 10 lm
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123decomposition soluble fraction appears, which can be then
solubilized in SBF solution and can foster phosphate
crystallization on the ﬁbre surface.
3.2 Adhesion and proliferation of osteoblast-like cells
on HAp modiﬁed and porous CFs
The numbers of cells colonizing the surface of CF/HAp,
CF/P or CF/T ﬁbres and the underlying bottom of the
culture wells on 1, 3 and 7 days after seeding are presented
in Fig. 5.
In 1-day-old cultures, most cells seeded into wells with
CFs adhered to the underlying well bottom. Only approx.
11,000–25,000 of cells were retained on the ﬁbres, which
was probably due to their narrow, elongated shape and thus
a relatively small effective area utilized for the cell adhe-
sion. The highest number of initially attached cells was
found on CFs modiﬁed with HAp, i.e. containing promi-
nences on their surface, while smooth ﬁbre surfaces (CF/T)
hindered the cell attachment in the greatest extent. How-
ever, similarly as in our earlier study performed on carbon–
carbon composites [29] prominences on the material sur-
face might hamper the subsequent cell proliferation. On
day 3 after seeding, the cell number on CF/HAp ﬁbres was
in average even lower than on day 1, and on day 7, the cells
on these ﬁbres attained a lower ﬁnal cell population density
than on CF/P and CF/T ﬁbres.
However, on the well bottom underlying the CF/HAp
ﬁbres, the cells proliferated better than in wells with the
other types of CFs, and on day 7 after seeding, their pop-
ulation density exceeded the value in control wells without
ﬁbres. A possible explanation is that HAp on the ﬁbres
might release bioactive ions, such as Ca or P, which sup-
ported the cell growth. Similarly, HAp islets deposited on
titanium-based composite materials partially dissolved in
the cell culture medium, which was associated with high
proliferation and alkaline phosphatase activity of osteo-
blastic SaOs-2 cells cultured in contact with these materials
[30]. Also ionic products of dicalcium silicate (Ca2SiO4)
coating, dissolved in the cell culture medium, enhanced the
proliferation activity and gene expression of bone differ-
entiation markers (i.e., alkaline phosphatase and osteocal-
cin) in MG 63 cells [28].
Results of observations of the morphology of cells
seeded on the surface of porous carbon ﬁbres (CF/P) and on
the surface of ﬁbres modiﬁed with HAp (CF/HAp) are
presented in Figs. 6 and 7 consequently. Morphology of
cells observed on both types of ﬁbres is very similar to the
morphology of cells incubated on control PS surface, i.e.
cells of both groups are mostly spindle-shaped (Fig. 6a).
Observed cells are uniformly spread along ﬁbres and cover
almost all their surface. Such a spreading of cells indicates
the good adhesion.
Taken together, cell counting and ﬂuorescence micros-
copy observations conﬁrmed good biocompatibility of CFs,
which is substantiated with both consecutively increasing
number of cells from day 1 to 7 after seeding and good
spreading of cells along the ﬁbre surface. The highest
initial adhesion of cells was found on CF/HAp ﬁbres, but
the subsequent proliferation was more pronounced on
CF/P and CF/T ﬁbres. Nevertheless, the CF/HAp ﬁbres
Fig. 4 EDS analysis for CF/HAp ﬁbres before (a) and after (b) immersion in SBF, (c) changes of ion concentration in SBF solution during
immersion of CF/HAp ﬁbres in SBF
Fig. 5 The correlation among the numbers of MG-63 cells adhering
and growing on various types of CFs and on the underlying well
bottoms on days 1, 3, and 7 after seeding. PS: standard polystyrene
cell culture well without ﬁbres, CF/HAp: carbon ﬁbres modiﬁed with
hydroxyapatite, CF/P: porous carbon ﬁbres or CF/T: standard carbon
ﬁbres. Mean ± SEM from 4 to 12 measurements, ANOVA Student–
Newman–Keuls method
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123stimulated in the greatest extent the proliferation of cells on
the underlying well bottom.
3.3 In vivo tests
3.3.1 Histological studies
Cutting of samples extracted from the site of implantation
together with the surrounding tissue were subjected to
histological tests. Parameters such as intensity of inﬂam-
mation process in tissues surrounding implanted ﬁbres, the
thickness of connective tissue formed around the implant,
progress of regeneration process as well as the effect of the
presence of CF ﬁbre fragments (i.e. products of degrada-
tion) on the process of tissue regeneration were evaluated.
Seven days after implantation, neutrophils and eosino-
phils were observed around the implanted ﬁbres. The
presence of cells responsible for combating infections
provides the information on the inﬂammatory inﬁltration,
associated with both the presence of foreign body (i.e.,
CFs) and the tissue injury as an effect of the implantation.
Neutrophils are the main cell types observed at early stages
of inﬂammations. They are directed into implantation place
in order to neutralize the injury and to prepare the tissue to
the self-reparation, so that their presence is indispensable to
start wound healing process.
An important ﬁnding was that different types of CFs
evoked a different response of the surrounding tissue on
day 7 after implantation. An extensive inﬂammatory exu-
date was observed in case of ﬁbres modiﬁed with HAp
(CF/HAp) (Fig. 8a) The presence of neutrophils evidenced
an acute inﬂammation.
In case of CF/P implant, the area of implantation was
narrow and surrounded with cells (Fig. 9a). Numerous
eosinophils were present; however no neutrophils were
observed. At early stages of inﬂammation the role of
eosinophils is similar to the role of neutrophils, that is they
eliminate and englobe inﬂammation factors, and on the
later stages of wound healing they provide additional
growth factors. Along with mast cells, the eosinophils also
are important mediators of allergic responses. After 7 days
from implantation of CF/P ﬁbres, the stage of acute
inﬂammation is ﬁnished, self-reparation takes place and
mast cells plays an essential role in regeneration processes.
Mast cells release chemical compounds (e.g. chemoat-
tractants and proteinases) enabling other cells of immune
system to reach the place of injury. Moreover they take part
in angiogenesis and processes of tissue repair, affecting
proliferation of ﬁbroblasts. In both cases the inﬂammatory
processes were not sustained.
After 30 days from implantation, differences in tissue
response to both types of implanted materials were more
pronounced (Figs. 8b, 9b). In the case of ﬁbres modiﬁed
with HAp, the observed implant is agglomerated and sur-
rounded with granulation tissue. In both kinds of implants,
foreign body-type multinucleated giant cells were observed
Fig. 6 Morphology of MG-63 cells seeded on porous CF/P ﬁbres after 7 days in culture: a cells on control PS plate and b–d cells on porous
CF/P ﬁbres. Stained with propidium iodide, microscope Olympus IX 51, digital camera DP 70, obj. 209, bar = 100 lm
Fig. 7 Morphology of osteoblast-like MG-63 cells incubated on CF/HAp ﬁbres after 7 days in culture. Stained with propidium iodide,
microscope Olympus IX 51, digital camera DP 70, obj. 209, bar = 100 lm
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The structure of the muscle tissue surrounding the implant
was regular. In the case of CF/P implants, CFs were located
close to muscle ﬁbres. The increased number of ﬁbroblasts
within the implant was typical for samples analyzed after
30 days from implantation.
Sections of implants after 210 days from implantation
are presented in Figs. 8c and 9c. In both cases one can
observe sites of direct contact of muscle ﬁbres and CFs,
moreover CFs do not disturb the functioning of muscle
ﬁbres.
Van Gieson staining protocol was assessed to analyze
the way of connecting the implant with surrounding tissues.
According to Van Gieson method as the effect of staining
collagen ﬁbres are getting red and muscles are getting
yellow. Implantation sites 1 week after surgery are pre-
sented in Figs. 10a and 11a.
Collagen layer visible on the border of muscle tissue and
inﬁltration surrounded both types of implanted ﬁbres in a
similar way. Within the region of inﬁltration, also loosely
dislocated collagen ﬁbres were apparent. During the ﬁrst
weeks after surgery, the site of implantation was embedded
with connective tissue capsule, and thus isolated from the
surrounding tissues. The thickness of capsule was
decreasing over time and ﬁnally it reached the dimensions
comparable with the spacing between muscle ﬁbres.
Fig. 8 Cross-section of rat skeletal muscle with implanted CF/HAp
carbon ﬁbres: a after 7 days from implantation (obj. 109,
bar = 200 lm); b after 30 days (obj. 109, bar = 200 lm) and c
after 210 days (obj. 209, bar = 100 lm). Microscope Olympus BX
51, digital camera CAMEDIA; staining according to Pappenheim
Fig. 9 Cross-section of rat skeletal muscle with implanted carbon
ﬁbres (CF/P) a after 7 days from implantation (obj. 109,
bar = 200 lm); b after 30 days (obj. 209, bar = 100 lm) and c
after 210 days (obj. 209, bar = 100 lm). Microscope Olympus BX
51, digital camera CAMEDIA; staining according to Pappenheim
Fig. 10 Cross-section of rat skeletal muscle with implanted CF/HAp
ﬁbres a after 7 days (obj. 109); b after 210 days (obj. 109) and c after
210 days (obj. 49); bar = 200 lm. Microscope Olympus BX 51,
digital camera CAMEDIA; Collagen ﬁbres surrounding the implant
are stained according to Van Gieson protocol
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The effect of implanted CFs on the metabolic state of
surrounding tissues as well as tissues growing into the
region of implants was analyzed using histochemical
methods. Those methods enable tracing changes in the
activity of enzymes speciﬁc for particular stages of the
inﬂammatory process observed directly after implantation,
and then during wound healing process. Activity of CCO
and acid phosphatase was analyzed. Selected enzymes are
particularly important for regular metabolism. CCO present
in mitochondrions is responsible for cellular respiration
and controls the transport of electrons. Acid phosphatase,
being a hydrolytic enzyme present in lysosomes (mostly in
phagocytes), enables decomposition of metabolites. Based
on mentioned above enzymes activities it is possible to
conclude on the advancement of the inﬂammatory process.
3.4 Acid phosphatase activity
Acid phosphatase activity provide information regarding
intensity of inﬂammatory process, however it is very
difﬁcult to estimate changes of acid phosphatase activity
on the rat skeletal muscle sections. The reaction of acid
phosphatase in the regions with CF/P and CF/HAp ﬁbres
30 days after implantation is presented in Fig. 12. Both
macrophages and multinucleated giant cells with high
enzymatic activities are visible in surroundings of CFs.
3.5 Cytochrome c oxidase analysis
Incaseofhistoenzymaticallyregularratskeletalmuscle,itis
possible to distinguish three types of skeletal muscles orga-
nized in mosaic form visible on the muscle cross-section.
Takingintoaccountactivityofoxidizingenzymespresentin
muscles, it may be stated that the activity is higher in case of
thinnerﬁbres,andlowerincaseofthickerones.Besidethick
and thin ﬁbres, ﬁbres which morphology and enzymatic
activity in an intermediate state are also present in the
muscle. Using histochemical methods it is possible to pro-
vide information regarding changes of enzymatical activity
of muscle ﬁbres such as dysregulation of mosaic structure,
lackofﬁbresdiversity,lackordecreaseofenzymaticactivity
or unequal enzymatic activity within ﬁbres cross-section.
Fig. 11 Cross-section of rat skeletal muscle with implanted CF/P ﬁbres: a after 7 days (obj. 109); b after 210 days (obj. 109) and c after
210 days (obj. 49), bar = 200 lm. Microscope Olympus BX 51, digital camera CAMEDIA; Staining according to Van Gieson protocol
Fig. 12 Cross-section of rat’s skeletal muscle. Acid phosphatase activity against a CF/HAp ﬁbres and (b–c) CF/P after 30 days. Microscope
Olympus BX 51, digital camera CAMEDIA; obj. 109, bar = 200 lm, obj. 209, bar = 100 lm
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metabolism of rat skeletal muscles tissue surrounding the
implant. The effect of implantation of CF/HAp and CF/P
on the CCO activity is presented in Figs. 13 and 14.
Regenerative processes were observed just after 7 days
from implantation (Fig. 13a). Fine blood vessels were
observed within granulation tissue growing into the
implanted materials and the regenerated muscle ﬁbres
appeared on the border between injured tissue and
implanted material. In subsequent streams of samples
granulation tissue within the implant was replaced by such
regenerated muscle ﬁbres. Biocompatibility of implanted
materials can be substantiated by the lack of connective
tissue capsule surrounding the implanted biomaterial
(Figs. 13c, d, 14a–c) and by the regenerating muscle cells
growing within the structure of implant. Moreover the
direct contact between implanted CFs and muscle tissues
was observed in numerous places; and both mosaic struc-
ture of ﬁbres and enzymatic activity remained unaltered.
4 Discussion
The assumption that carbon as the fundamental element in
biological tissues would not induce adverse reactions
encouraged scientists to use carbon ﬁbers in medicine as
the implantable biomaterial [1]. In the ﬁeld of regenerative
medicine carbon materials are becoming increasingly
attractive as they can be modiﬁed to be integrated into
human bodies for promotion of tissue regeneration and
treatment of various diseases.
Properties of CFs important for medical applications are
related to the physical and chemical structure of their
surface, as well as to the broad possibility of customize of
their mechanical properties, so that the ﬁbers’ properties
should be comparable with the tissues replaced. Based on
microscopic observations we have conﬁrmed that adhesion
of cells to porous ﬁbers which were of highest accessible
surface within analyzed samples was much better than in
case of the other types of analyzed ﬁbers. According to in
vivo studies, CF/P ﬁbers due to their signiﬁcant porosity
enable more efﬁcient growing of cells and connective tis-
sue within the structure of implant.
Biocompatibility of CFs has been the subject of
numerous researches, however individual researchers
implemented it in their own experiments without further
physical and chemical characterization, and also without
specifying the sterilization methods, so that cases of toxic
effects of ﬁber degradation products on the human body
were also reported [31–33]. CF in many cases were well
tolerated by the recipient and did not cause the around
foreign body reactions [6]. Moreover the tendon or
Fig. 13 Cytochrome c oxidase activity on a cross-section of rat
skeletal muscle implanted with CF/HAp ﬁbres a after 7 days, b after
90 days (obj. 109, bar = 200 lm); c–d after 210 days (obj. 109,
bar = 200 lm; obj. 209, bar = 100 lm); Microscope Olympus BX
51, digital camera CAMEDIA
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123ligament newly developed on a carbon scaffold was mor-
phologically very similar and functionally identical to the
replaced natural structure [8]. It has been demonstrated by
the later studies that the cellular response to the ﬁbrous
carbon material depends on the degree of crystallinity of
the material; highly crystalline, high modulus ﬁbers are not
suitable for medical purposes, while amorphous ﬁbers are
excellent for implants [6]. Grabinski et al. [34] reported
that toxicity of carbon materials depends also of dimen-
sions and after 24 h the carbon nanotubes showed
increased cellular toxicity when compared to the carbon
ﬁbers and carbon nanoﬁbers. It was also substantiated by
Elias et al. [35] for carbon nanoﬁbers obtained by chemical
vapor deposition. The average diameter of presented in this
paper ﬁbers after carbonization was at the range of 10 lm.
Our results clearly demonstrated the excellent biocompat-
ibility of those carbon ﬁbers, however they also clearly
conﬁrmed that biological activity is even more desirable.
The lack of bioactivity would result in formation of con-
nective tissue capsule around the implant, as the implanted
material would not integrate with the tissue and therefore
restricts extensive use of CFs in bone tissue replacement.
The presence of HAp on the surface of biomaterial improve
its bioactivity. In our study we have proved that by the
addition of hydroxyapatite to the spinning solution is
possible to obtain effect of modiﬁcation on the ﬁbers
surface. This modiﬁcation improved the bioactivity as
observed from in vitro studies in SBF and which was
further also evidenced by better cell adhesion and prolif-
eration. According to in vivo studies the non-sustained
inﬂammatory exudates were observed in case of carbon
ﬁbers modiﬁed with hydroxyapatite, following prolifera-
tion phase. The time of inﬂammatory was shorter than in
case of traditional carbon ﬁbers and the thin connective
tissue capsule was formed just after 90 days from
implantation, which evidence the proper healing of injury
with implanted ﬁbers, so that also ﬁbers biocompatibility
(in case of traditional CF ﬁbers it is observed after
210 days). There are other studies regarding modiﬁcations
of carbon materials. Liu et al. [36] proved that CNFs
modiﬁed with b-TCP possess good biocompatibility and
exhibit more favorable properties for cell growth as com-
pared to pure CNFs. Hong-mei et al. [19, 37] have used
electrocrystallization process in order to deposit calcium
phosphate on the surface of carbon fabrics. By coating
carbon fabrics with calcium phosphate they enhanced cell
attachment and proliferation. Su-ping et al. [38] mentioned
that CFs after chemical modiﬁcation can induce calcium
phosphate crystal growing on its surface by the process of
biomineralization. Modiﬁcation of PAN spinning solution
before coagulation of ﬁbers has rendered successful as
HAp particles were observed on the surface of carbon
ﬁbers after carbonization process. The proposed approach
allows to avoid the post treatment operations, such as
chemical modiﬁcation of ﬁbers or post-treatment by coat-
ing with ﬁlms, which were usually necessary in order to
obtain bioactive character of implants. Fibers produced on
the proposed way with addition of HAp to the spinning
solution are bioactive and biocompatible. However it
would be interesting to be able to combine advantages of
porous ﬁbers which make them the best from the cells
adhesion point of view with advantages of HAp modiﬁ-
cation which considerably improves bioactivity of CFs.
5 Conclusions
On the basis on provided analysis, the following conclu-
sions can be derived:
• CF/HAp ﬁbres are bioactive. Modiﬁcation of the ﬁbres
with HAp promotes formation of apatite on the ﬁbre
surface during incubation in SBF.
• Analyzed materials did not have cytotoxic effects.
• Modiﬁcation of ﬁbres with HAp improved the initial
adhesion of human osteoblast-like cells on the ﬁbre
surface and proliferation of these cells in polystyrene
wells at presence of HAp-modiﬁed ﬁbres in the cell
culture medium. Also the presence of pores in CF/P
ﬁbres improved proliferation of MG 63 cells.
• After implantation of CFs into rat skeletal muscle in
vivo, a direct contact of ﬁbres and surrounding tissues
Fig. 14 Cytochrome c oxidase activity on a cross-section of rat skeletal muscle implanted with CF/P ﬁbres a–c after 210 days (obj. 109,
bar = 200 lm; obj. 409, bar = 50 lm). Microscope Olympus BX 51, digital camera CAMEDIA
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123indicates good healing of tissues with implanted
materials.
• The presence of regenerated ﬁbres indicates that CFs
enhance the process of self-reparation of rat skeletal
muscle injured during the in vivo implantation.
• All types of the studied CFs stimulated the growth of
connective tissue in vivo, manifested by formation
of ﬁbrous capsule around the implant. On the other
hand, modiﬁcations of ﬁbres with pores and HAp
accelerated the reduction of the capsule thickness.
In CF/P and CF/HAp ﬁbres, the thickness of connec-
tive tissue capsule was reduced effectively after 30
and 90 days from implantation, respectively, while in
non-modiﬁed ﬁbres, it lasted almost 210 days [39].
Thus, CFs modiﬁed with pores or HAp enhance tissue
regeneration.
• The process of tissue regeneration in vivo was not
disturbed by the presence of the material decomposition
products.
• In case of CFs modiﬁed with hydroxyapatite also the
non-sustained inﬂammatory exudate was observed.
However, the duration of inﬂammatory response was
shorter than in case of traditional CFs. Only a thin
connective tissue capsule was formed, which evidenced
the proper healing of injury with implanted ﬁbres, and
thus biocompatibility of the ﬁbres.
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